Literature DB >> 17207388

The serum levels of resistin in rheumatoid arthritis patients.

K Migita1, Y Maeda, T Miyashita, H Kimura, M Nakamura, H Ishibashi, K Eguchi.   

Abstract

OBJECTIVE: Adipocyte-derived resistin is a circulating protein implicated in insulin resistance, but the role of human resistin is uncertain because it is produced largely by macrophages. The aim of this study was to analyze serum resistin concentrations in rheumatoid arthritis (RA) patients to determine the role of resistin in human inflammatory diseases.
MATERIALS AND METHODS: Resistin concentrations were assessed by ELISA in serum samples from 42 patients with RA. Serum samples from 38 healthy subjects acted as controls. We also evaluated the circulating levels of tumor necrosis factor- alpha (TNF-alpha) and disease activity markers in RA patients.
RESULTS: In RA patients, serum resistin levels were significantly higher than those in healthy subjects. Serum resistin levels in RA patients were correlated with the RA disease activity markers, CRP and ESR. Furthermore, resistin levels in RA patients were significantly correlated with circulating levels of TNF-alpha.
CONCLUSION: Serum resistin levels were significantly increased in RA patients and correlated with inflammatory markers and TNF-alpha, suggesting that resistin may play a role in the rheumatoid inflammatory process.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17207388

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  31 in total

1.  Serum resistin levels in patients with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis.

Authors:  Qing Huang; Sha-Sha Tao; Yu-Jing Zhang; Chao Zhang; Lian-Ju Li; Wei Zhao; Meng-Qin Zhao; Peng Li; Hai-Feng Pan; Chen Mao; Dong-Qing Ye
Journal:  Clin Rheumatol       Date:  2015-05-03       Impact factor: 2.980

2.  Human resistin protects against endotoxic shock by blocking LPS-TLR4 interaction.

Authors:  Jessica C Jang; Jiang Li; Luca Gambini; Hashini M Batugedara; Sandeep Sati; Mitchell A Lazar; Li Fan; Maurizio Pellecchia; Meera G Nair
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-13       Impact factor: 11.205

Review 3.  Adipokines in bone disease.

Authors:  Elena Neumann; Susann Junker; Georg Schett; Klaus Frommer; Ulf Müller-Ladner
Journal:  Nat Rev Rheumatol       Date:  2016-04-15       Impact factor: 20.543

4.  Serum resistin concentrations in children with Kawasaki disease.

Authors:  Hiroki Nozue; Hironori Imai; Hisako Saitoh; Takeshi Aoki; Kunio Ichikawa; Tomohiro Kamoda
Journal:  Inflamm Res       Date:  2010-04-27       Impact factor: 4.575

5.  GCF Resistin As A Novel Marker in Patients with Chronic Periodontitis and Rheumatoid Arthritis.

Authors:  Manoj Mittal; Basit Hassan; Khushboo Desai; Shilpa Duseja; Santosh Kumar; Sharaschandra G Reddy
Journal:  J Clin Diagn Res       Date:  2015-04-01

6.  Resistin up-regulates COX-2 expression via TAK1-IKK-NF-kappaB signaling pathway.

Authors:  Jian Zhang; Ting Lei; Xiaodong Chen; Yin Peng; Huan Long; Lei Zhou; Jianfeng Huang; Zhilong Chen; Qinqiang Long; Zaiqing Yang
Journal:  Inflammation       Date:  2010-02       Impact factor: 4.092

Review 7.  Vascular effects of biologic agents in RA and spondyloarthropathies.

Authors:  Zoltán Szekanecz; György Kerekes; Pál Soltész
Journal:  Nat Rev Rheumatol       Date:  2009-11-10       Impact factor: 20.543

8.  Resistin in inflammatory and degenerative rheumatologic diseases. Relationship between resistin and rheumatoid arthritis disease progression.

Authors:  S M H Fadda; S M Gamal; N Y Elsaid; A M Mohy
Journal:  Z Rheumatol       Date:  2013-08       Impact factor: 1.372

9.  Elevated serum resistin in juvenile idiopathic arthritis: relation to categories and disease activity.

Authors:  Tamer A Gheita; Iman I El-Gazzar; Reem I El Shazly; Abeer M Nour El-Din; Enas Abdel-Rasheed; Rasha H Bassyouni
Journal:  J Clin Immunol       Date:  2012-08-11       Impact factor: 8.317

Review 10.  The role of resistin in inflammatory myopathies.

Authors:  Mária Filková; Ladislav Senolt; Jiří Vencovský
Journal:  Curr Rheumatol Rep       Date:  2013-06       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.